Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

GNOMvsFMEDETF Comparison

ETF 1
GNOM

Global X Genomics & Biotechnology ETF

This fund is part of
BioTech & Genomics
+3.8%
VS
ETF 2
FMED

Fidelity Disruptive Medicine ETF

This fund is part of
Multiple Trends
+5.9%

Global X Genomics & Biotechnology ETF (GNOM) belongs to the BioTech & Genomics segment. Fidelity Disruptive Medicine ETF (FMED) is part of the Multiple Trends segment. GNOM's top 3 sector exposures are Healthcare and Industrials. In contrast, FMED's top sector exposures are Healthcare  Both GNOM and FMED have the same Total Expense Ratio (TER) of 0.5%. GNOM is up 21.83% year-to-date (YTD) with +$18M in YTD flows. FMED performs worse with 5.96% YTD performance, and -$17M in YTD flows. Run a side-by-side ETF comparison of GNOM and FMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

GNOM vs FMED performance and flow charts

Performance

-6.0-4.0-2.00.02.04.06.0%Jun 30Jul 8Jul 15Jul 22Jul 29

Cumulative Flows

02,000,0004,000,0006,000,0008,000,00010,000,000Jun 30Jul 8Jul 15Jul 22Jul 29

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/30/2026
1M3MYTD1Y3Y5Y
Perf.
GNOM
FMED
-2.19%+0.45%
+22.58%+15.63%
+21.83%+5.96%
+58.30%+19.83%
+14.80%+13.57%
-38.54%n/a
Flows
GNOM
FMED
+$7M-
+$19M-$17M
+$18M-$17M
+$13M-$14M
-$95M-$3M
-$862K-
Volatility and drawdown
3M1Y3Y5Y
Volatility
GNOM
FMED
+28.16%+21.64%
+26.78%+19.54%
+29.11%+18.58%
+33.32%n/a
Max drawdown
GNOM
FMED
-8.57%-5.92%
-18.16%-17.78%
-43.10%-21.33%
-72.01%n/a
Max drawdown duration
GNOM
FMED
24d21d
145d212d
674d210d
1792dn/a
Trading data

Create an account to view trading data

Join for free
GNOM
FMED
Last sale
7/31/2026 at 3:22 PM
$53.88
Previous close
07/30/2026
$55.39
Consolidated volume
07/30/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

FMED
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
GNOM
FMED
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/31/2026 at 3:22 PM
Live
Closed
GNOM
FMED
Last price
$53.88
1D performance
-2.73%
AuM$81.18 M$46.62 M
E/R0.5%0.5%
Characteristics
GNOM
FMED
Management strategyPassiveActive
ProviderGlobal XFidelity
BenchmarkSolactive Genomics Index-
N° of holdings5069
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateApril 5, 2019June 12, 2023
ESGNoNo
Advertisement
Exposure

Countries

GNOM
USA
84.1%
Other
15.9%
FMED
USA
83.89%
Other
16.11%

Sectors

GNOM
Healthcare
99.75%
Other
0.25%
FMED
Healthcare
100%
Other
-0%

Diversification

GNOM

Total weight of top 15 holdings out of 15

61.22%
FMED

Total weight of top 15 holdings out of 15

41.87%

Top 15 holdings

Data as of June 30, 2026
GNOM
Guardant Health, Inc.
5.78%
Twist Bioscience Corp.
5.09%
Illumina, Inc.
4.67%
Natera, Inc.
4.41%
Moderna, Inc.
4.22%
Veracyte, Inc.
4.12%
Bio-Techne Corp.
4.08%
Vertex Pharmaceuticals, Inc.
3.85%
Legend Biotech Corp.
3.82%
10X Genomics, Inc.
3.70%
Arrowhead Pharmaceuticals, Inc.
3.67%
BioMarin Pharmaceutical, Inc.
3.59%
Praxis Precision Medicines, Inc.
3.50%
CRISPR Therapeutics AG
3.36%
QIAGEN NV
3.35%
FMED
Lifestance Health Group, Inc.
5.11%
10X Genomics, Inc.
3.56%
Danaher Corp.
3.29%
UCB SA
3.09%
Cogent Biosciences, Inc.
2.79%
Bio-Techne Corp.
2.76%
Moderna, Inc.
2.69%
Intuitive Surgical, Inc.
2.49%
argenx SE
2.43%
Alnylam Pharmaceuticals, Inc.
2.41%
Kymera Therapeutics, Inc.
2.36%
UnitedHealth Group, Inc.
2.27%
Thermo Fisher Scientific, Inc.
2.24%
Ascendis Pharma A/S
2.21%
Legend Biotech Corp.
2.17%
Frequently asked questions about GNOM and FMED

How have the GNOM and FMED ETFs performed in 2026?

As of July 30, 2026, GNOM is up 21.83% year-to-date (YTD), while FMED has returned 5.96%. That puts GNOM better performer ahead so far this year.

Which ETF is attracting more investor money: GNOM or FMED?

Year-to-date, the GNOM ETF saw +$18M in flows, compared to -$17M for FMED.

Which ETF is more volatile: GNOM or FMED?

Over the past year, GNOM had a volatility of 26.78%, while FMED experienced 19.54%.

Which ETF is bigger: GNOM or FMED?

As of July 30, 2026, GNOM holds $81.18 M in assets under management (AUM), while FMED manages $46.62 M.

What sectors do the GNOM and FMED ETFs invest in?

GNOM leans toward sectors like Healthcare. Meanwhile, FMED focuses on Healthcare.

What are the top holdings of the GNOM ETF and FMED ETF?

GNOM top holdings include Guardant Health, Inc., Twist Bioscience Corp. and Illumina, Inc.. FMED holds in its top three: Lifestance Health Group, Inc., 10X Genomics, Inc. and Danaher Corp..

Which ETF is more diversified: GNOM or FMED?

GNOM holds 50 securities with 61.22% of its assets in the top 15. FMED has 69 securities and a top 15 weight of 41.87%.

Advertisement
Advertisement
Advertisement
Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.

Global ETF Survey 2026